CD4-positive helper T lymphocyte (CD4+ T cell)

Molecular Classification

Lymphocyte, T cell (a subtype of lymphocyte), Immune cell, Surface marker: CD4, Receptor-bearing cell (T cell receptor, TCR), Other: Can differentiate into subsets (Th1, Th2, Th17, Treg, Tfh, Th9, Th22) based on cytokine profile and function[1][4][6]

Other Names

T helper lymphocyte, T helper cell, CD4+ T cell, CD4 T lymphocyte, CD4-positive T cell, Th cell, Helper T cell

Disease Roles

Infection (especially HIV, which targets and destroys CD4+ T cells)[2][7]Cancer (immunosurveillance and regulatory functions)[6]Autoimmune disease (genetic variation affects susceptibility)[1][4]

CD4-positive helper T lymphocyte Overview

CD4-positive helper T lymphocytes are a principal subset of T cells critical for the proper functioning of the adaptive immune system[1][2][3]. They are identified by the presence of CD4 on their surface, which serves as a coreceptor for the major histocompatibility complex class II (MHC-II) on antigen-presenting cells. Upon activation, CD4+ T cells differentiate into specialized subtypes including Th1, Th2, Th17, Treg, and Tfh cells, each with distinct cytokine profiles and immune functions[4][6]. These cells orchestrate immune responses by stimulating B cells for antibody production, activating cytotoxic T cells and macrophages, and regulating inflammatory processes. CD4+ T cell depletion, especially due to HIV infection, leads to severe immunodeficiency, making their enumeration and preservation a key focus in infectious disease therapy and monitoring[2][7]. Their dysregulation is implicated in autoimmunity, cancer, and exacerbated inflammatory responses[1][4][6].

Mechanism of Action

Inhibition of viral entry or replication (ART drugs prevent HIV from infecting or destroying CD4+ T cells)[2] Suppression of immune function (immunosuppressants reduce T cell activation, cytokine production)[4] Modulation of cytokine signaling or subset differentiation (biologics target specific cytokines produced by T cell subsets)[4][6]

Biological Functions

Immune response coordination and regulation

Activation of other immune cells (e.g., B cells for antibody production, cytotoxic T cells, macrophages and neutrophils via cytokines)[1][2][3]

Cytokine secretion

B cell antibody class switching

Development of immunological memory (memory T cell formation)[2]

Suppression of immune response and prevention of autoimmunity (for regulatory T cells)[2][4]

Formation of germinal centers and affinity maturation (for follicular helper T cells)[4]

Disease Associations

Infection (especially HIV, which targets and destroys CD4+ T cells)[2][7]

Cancer (immunosurveillance and regulatory functions)[6]

Autoimmune disease (genetic variation affects susceptibility)[1][4]

Inflammation

Other: Roles in allergic response (Th2), fungal and parasitic infection control (Th17, Th2)[2][4]

Safety Considerations

Risk of immune suppression leading to secondary infections (when CD4+ T cells are depleted, e.g., in HIV/AIDS or after immunosuppression)[2][7]
Risk of autoimmunity when regulatory T cell function is impaired[1][4]
Immune reconstitution inflammatory syndrome (IRIS) after rapid restoration of CD4+ T cells in immunosuppressed patients[2]
Cytokine storm or excess inflammation due to dysregulated T cell function[2][4]

Interacting Drugs

Antiretroviral therapy (ART) drugs for HIV (e.g., zidovudine, lamivudine, efavirenz, tenofovir)[2]

Immunosuppressive drugs (targeting T cell activation/function; e.g., cyclosporine, corticosteroids)[4]

Biologic agents modulating cytokines or T cell subsets (e.g., anti-IL-17, anti-IL-6 therapies; more specific for Th17 and Th1/Th2 balance)[4][6]

Associated Biomarkers

Biomarker
CD4+ T cell count (monitoring HIV progression; assessing immunodeficiency)[2][7]
Surface markers for subsets (e.g., CXCR3, CD161 for Th1, CXCR5 for Tfh, CTLA-4 and CD25 for Treg)[4]
Cytokine profiles depending on subset (measured in research and diagnostics)[4]